Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -52.08 | N/A |
PEG Ratio (TTM) | -0.74 | N/A |
P/S Ratio (TTM) | 0.67 | N/A |
P/B Ratio (TTM) | 2.21 | N/A |
P/FCF Ratio (TTM) | 25.02 | N/A |
Price to 5YR AVG Earnings Ratio | -0.61 | N/A |
Price to 5YR AVG FCF Ratio | -2.73 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -2.17% | N/A |
ROE (TTM) | -5.23% | N/A |
Net Profit Margin (TTM) | -1.25% | N/A |
ROIC 5YR AVG | -155.36% | N/A |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 146.80% | 14.95% | 35.36% |
Revenue | 4.78% | -0.75% | 6.03% |
Net Income | 127.42% | -3.07% | 18.21% |
Cash Flow | -1,244.74% | -18.45% | 7.73% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.41 | N/A |
Quick Ratio (TTM) | 2.00 | N/A |
D/E Ratio (TTM) | 0.30 | N/A |
Interest Coverage (TTM) | 0.28 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.47 | N/A |
Shares Outstanding Growth 5YR AVG | 43.12% | N/A |